Maintenance of KSHV-infected Cell Lines
Corresponding Organization :
Other organizations : Johns Hopkins Medicine, Johns Hopkins University
Variable analysis
- Use of recombinant rKSHV.219 virus
- Use of recombinant baculovirus BacK50
- Presence of puromycin (5 µg/ml)
- GFP positivity
- Cell lines grown in minimal essential medium (alpha medium– Gibco Invitrogen) supplemented with 10% fetal bovine serum (FBS– Gibco Invitrogen)
- Cell lines passaged as described previously [27]
- Vero cell line carrying the recombinant rKSHV.219 virus and the recombinant baculovirus BacK50 obtained from Jeffery Vieira [26]
- ISLK cell line developed by the Ganem Lab [28] obtained from Jae Jung
- 5r219 cells maintained in 10 µg/ml puromycin continuously
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!